Annandale Capital »

Rocket Pharmaceuticals shares owned by Annandale Capital

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $66k 3.2k 20.50

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Global X Fds Glb X Mlp Enrg I (MLPX)
Uber Technologies (UBER)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Annandale Capital

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Maverick Capital
BlackRock
Vanguard Group
MPM Oncology Impact Management
Suvretta Capital Management
Millennium Management
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Two Sigma Advisers
State Street Corporation

View all funds holding Rocket Pharmaceuticals